Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Molecular Biology
Reference63 articles.
1. Beghini, A. et al. KIT activating mutations: incidence in adult and pediatric acute myeloid leukemia, and identification of an internal tandem duplication. Haematologica 89, 920–925 (2004).
2. Bacher, U., Haferlach, C., Kern, W., Haferlach, T. & Schnittger, S. Prognostic relevance of FLT3-TKD mutations in AML: the combination matters--an analysis of 3082 patients. Blood 111, 2527–2537 (2008).
3. Vainchenker, W., & Constantinescu, S. N. A unique activating mutation in JAK2 (V617F) is at the origin of polycythemia vera and allows a new classification of myeloproliferative diseases. Education Program, 195–200 (2005).
4. Shtivelman, E., Lifshitz, B., Gale, R. P. & Canaani, E. Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature 315, 550–554 (1985).
5. Carter, T. A. et al. Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases. Proc. Natl Acad. Sci. USA 102, 11011–11016 (2005).
Cited by
168 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献